• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Schrodinger Inc (NQ: SDGR )

    18.77 -0.01 (-0.05%)
    Streaming Delayed Price Updated: 12:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Schrodinger Inc

    < Previous 1 2 3 4 5 Next >
    Schrödinger to Present at Jefferies London Healthcare Conference
    From Schrödinger
    Via Business Wire
    Schrödinger to Announce Third Quarter 2024 Financial Results on November 12
    From Schrödinger
    Via Business Wire
    Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger to Present at Morgan Stanley Global Healthcare Conference
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Strong Second Quarter 2024 Financial Results
    From Schrödinger
    Via Business Wire
    Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology
    From Schrödinger
    Via Business Wire
    Schrödinger to Announce Second Quarter 2024 Financial Results on July 31
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Simulations Plus Stock Drops 15% Despite EPS Beat
    Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance. 
    Via MarketBeat
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger to Present at Jefferies Global Healthcare Conference
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger Reports First Quarter 2024 Financial Results
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger to Announce First Quarter 2024 Financial Results on May 1
    From Schrödinger
    Via Business Wire
    Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results
    From Schrödinger
    Via Business Wire
    Schrödinger to Participate in Upcoming Investor Conferences
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals
    From Schrödinger
    Via Business Wire
    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Schrödinger
    Via Business Wire
    Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event
    From Schrödinger
    Via Business Wire
    Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting
    From Schrödinger
    Via Business Wire
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.